CRISPR Therapeutics AG Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARK INVESTMENT MANAGEMENT LLC | 05/12/2026 | 11.31 M | $538.19 M | 7.52% | 12.58% |
| BLACKROCK, INC. | 05/13/2026 | 7.68 M | $365.34 M | 2.29% | 8.54% |
| ORBIS ALLAN GRAY LTD | 05/15/2026 | 6.11 M | $290.46 M | 2.62% | 6.79% |
| CAPITAL WORLD INVESTORS | 05/13/2026 | 4.73 M | $224.77 M | 100.00% | 5.25% |
| STATE STREET CORP | 05/15/2026 | 3.98 M | $189.45 M | 6.10% | 4.43% |
| GSK PLC | 05/14/2026 | 3.22 M | $153.21 M | 0.00% | 3.58% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 05/15/2026 | 2.95 M | $140.46 M | -8.49% | 3.28% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 2.38 M | $113.10 M | 5.69% | 2.64% |
| SR ONE CAPITAL MANAGEMENT, LP | 05/14/2026 | 2.04 M | $96.98 M | 0.00% | 2.27% |
| FMR LLC | 05/15/2026 | 1.95 M | $92.98 M | 0.04% | 2.17% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 04/30/2026 | 1.85 M | $88.19 M | -5.32% | 2.06% |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 05/07/2026 | 1.85 M | $88.19 M | -5.32% | 2.06% |
| UBS GROUP AG | 05/05/2026 | 1.76 M | $83.84 M | -30.17% | 1.96% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 1.48 M | $70.55 M | 215.13% | 1.65% |
| ECOR1 CAPITAL, LLC | 05/15/2026 | 1.39 M | $66.09 M | 0.00% | 1.54% |
| CAPITAL INTERNATIONAL INVESTORS | 05/13/2026 | 1.19 M | $56.46 M | -79.86% | 1.32% |
| 05/15/2026 | 1.14 M | $54.35 M | 100.00% | 1.27% | |
| NEA MANAGEMENT COMPANY, LLC | 05/15/2026 | 1.06 M | $50.36 M | 0.00% | 1.18% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 1.04 M | $49.44 M | 0.89% | 1.16% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 983.07 K | $46.76 M | -10.38% | 1.09% |
| LOOMIS SAYLES & CO L P | 05/14/2026 | 968.14 K | $46.05 M | 7.65% | 1.08% |
| NORTHERN TRUST CORP | 05/14/2026 | 802.18 K | $38.16 M | 6.23% | 0.89% |
| MORGAN STANLEY | 05/15/2026 | 668.14 K | $31.78 M | 0.16% | 0.74% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 593.41 K | $28.23 M | -30.51% | 0.66% |
| JANE STREET GROUP, LLC | 05/12/2026 | 576.00 K | $27.40 M | 2.60% | 0.64% |
| CITADEL ADVISORS LLC | 05/15/2026 | 572.30 K | $27.22 M | -24.52% | 0.64% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 566.40 K | $26.94 M | 2.91% | 0.63% |
| 05/08/2026 | 546.83 K | $26.01 M | 100.00% | 0.61% | |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 542.68 K | $25.82 M | 100.00% | 0.60% |
| CITADEL ADVISORS LLC | 05/15/2026 | 516.35 K | $24.56 M | 92.90% | 0.57% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 494.22 K | $23.49 M | -45.52% | 0.55% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 487.30 K | $23.18 M | -29.77% | 0.54% |
| JPMORGAN CHASE & CO | 05/13/2026 | 457.64 K | $20.29 M | -15.71% | 0.51% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 414.22 K | $19.70 M | 50.28% | 0.46% |
| IQ EQ FUND MANAGEMENT (IRELAND) LTD | 05/11/2026 | 400.88 K | $19.07 M | 2.92% | 0.45% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 377.18 K | $17.94 M | 1,136.97% | 0.42% |
| BANK OF NEW YORK MELLON CORP | 05/05/2026 | 311.38 K | $14.81 M | 0.14% | 0.35% |
| PEAK6 LLC | 05/14/2026 | 295.90 K | $14.08 M | 7.80% | 0.33% |
| AMERIPRISE FINANCIAL INC | 05/15/2026 | 286.84 K | $13.64 M | -3.50% | 0.32% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 280.71 K | $13.35 M | -11.97% | 0.31% |
| CITADEL ADVISORS LLC | 05/15/2026 | 258.90 K | $12.32 M | -55.26% | 0.29% |
| VESTMARK ADVISORY SOLUTIONS, INC. | 05/15/2026 | 256.78 K | $12.21 M | 2.90% | 0.29% |
| JANE STREET GROUP, LLC | 05/12/2026 | 252.10 K | $11.99 M | -26.54% | 0.28% |
| RAYMOND JAMES FINANCIAL INC | 05/14/2026 | 220.27 K | $10.48 M | 31.78% | 0.25% |
| NUVEEN, LLC | 04/30/2026 | 190.77 K | $9.07 M | 4.03% | 0.21% |
| SWISS NATIONAL BANK | 05/07/2026 | 169.70 K | $8.07 M | 5.08% | 0.19% |
| ROYAL BANK OF CANADA | 05/15/2026 | 163.72 K | $7.79 M | -1.11% | 0.18% |
| TD ASSET MANAGEMENT INC | 05/11/2026 | 158.42 K | $7.54 M | 0.00% | 0.18% |
| UBS ASSET MANAGEMENT AMERICAS INC | 05/13/2026 | 157.40 K | $7.49 M | 5.71% | 0.18% |
| PICTET ASSET MANAGEMENT HOLDING SA | 04/22/2026 | 154.01 K | $6.87 M | -8.04% | 0.17% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
CRISPR Therapeutics AG institutional Ownership - FAQ's
During the previous two years, 652 institutional investors and hedge funds held shares of CRISPR Therapeutics AG. The most heavily invested institutionals were:
ARK Investment Management LLC: 11.31 M
BlackRock, Inc.: 7.68 M
Orbis Allan Gray Ltd: 6.11 M
Capital World Investors: 4.73 M
STATE STREET CORP: 3.98 M
GSK PLC: 3.22 M
85.79% of CRISPR Therapeutics AG stock is owned by institutional investors.
Institutional investors have bought a total of 85.24 M shares in the last 24 months. This purchase volume represents approximately $5.01 B in transactions.